Search

everythinglearnresearchcommunity

for

Search:↓

A baby boy had two types of temporary hair loss at birth, which might be two forms of newborn hair loss combined.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Post-COVID-19 patients are at risk for hair loss.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Weight loss can cause temporary hair loss, especially in women and older adults.

Hair loss increases between July and October, possibly due to UV light, and factors like skin type, hair color, and density may affect this. Dandruff can worsen hair loss conditions.

COVID-19 may cause hair loss months after infection.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

The study concluded that neonatal occipital alopecia is common, not caused by physical friction, and usually resolves on its own without treatment.

The debate focuses on the role of catagen and hair shedding mechanisms in telogen effluvium.

A 17-year-old girl has had repeated hair loss since childhood, which can be triggered by infections like COVID-19.

Taking fluconazole for fungal infections might cause hair loss after about 3 months.

The poem ends by asking for case reports on serious health issues like Telogen Effluvium.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

A woman had temporary hair loss due to stress from a spinal cord injury.

Scalp treatments increased hair density and reduced hair loss in Telogen Effluvium patients.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Collagen CLR and placenta extract may help treat diffuse hair loss.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Accurate diagnosis is crucial to distinguish telogen effluvium from male pattern baldness to avoid unnecessary treatments.